Law360, New York (November 01, 2011, 1:18 PM ET) -- Novartis Pharmaceuticals Corp. on Monday won summary judgment in a Georgia suit remanded from multidistrict litigation claiming the company failed to warn that its bone drugs Aredia and Zometa were linked to bone death in the jaw.
Novartis has so far scored victories in two trials stemming from state or federal consolidated products liability litigation over Aredia and Zometa. The company is hoping for a retrial in a third case in which a jury initially told Novartis to pay $12.8 million to the plaintiff, but a...
Novartis Shakes Suit Over Bone Drug Warnings
To view the full article, take a free trial now.
